These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12505220)

  • 1. Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarction.
    Cannon CP
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV30-6. PubMed ID: 10492851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors.
    Cornara S; Mandurino-Mirizzi A; Somaschini A; Mauri S; Crimi G; Munafò A; Camporotondo R; Gnecchi M; De Servi S; De Ferrari GM; Ferlini M
    J Cardiovasc Med (Hagerstown); 2024 Feb; 25(2):173-175. PubMed ID: 38149704
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute profound abciximab induced thrombocytopenia: a correct management of a methodological error.
    Tanzilli G; Sordi M; Arrivi A; Mangieri E; Scappaticci M
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21977060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial.
    D'Amario D; Restivo A; Leone AM; Vergallo R; Migliaro S; Canonico F; Galli M; Trani C; Burzotta F; Aurigemma C; Niccoli G; Buffon A; Montone RA; Flex A; Franceschi F; Tinelli G; Limbruno U; Francese F; Ceccarelli I; Borovac JA; Porto I; Crea F
    Trials; 2020 Feb; 21(1):192. PubMed ID: 32066489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial.
    Park K; Cho YR; Park JS; Park TH; Kim MH; Kim YD
    J Cardiovasc Transl Res; 2018 Feb; 11(1):42-49. PubMed ID: 29344840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris.
    Williams RP; de Waard GA; De Silva K; Lumley M; Asrress K; Arri S; Ellis H; Mir A; Clapp B; Chiribiri A; Plein S; Teunissen PF; Hollander MR; Marber M; Redwood S; van Royen N; Perera D
    Am J Cardiol; 2018 Jan; 121(1):1-8. PubMed ID: 29132649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for intracoronary administration of abciximab.
    Romagnoli E; Burzotta F; Trani C; Biondi-Zoccai GG; Giannico F; Crea F
    J Thromb Thrombolysis; 2007 Feb; 23(1):57-63. PubMed ID: 17160551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina.
    Marzilli M; Sambuceti G; Testa R; Fedele S
    J Am Coll Cardiol; 2002 Dec; 40(12):2102-9. PubMed ID: 12505220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
    Batchelor WB; Tolleson TR; Huang Y; Larsen RL; Mantell RM; Dillard P; Davidian M; Zhang D; Cantor WJ; Sketch MH; Ohman EM; Zidar JP; Gretler D; DiBattiste PM; Tcheng JE; Califf RM; Harrington RA
    Circulation; 2002 Sep; 106(12):1470-6. PubMed ID: 12234950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
    Lincoff AM; Califf RM; Anderson KM; Weisman HF; Aguirre FV; Kleiman NS; Harrington RA; Topol EJ
    J Am Coll Cardiol; 1997 Jul; 30(1):149-56. PubMed ID: 9207636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy.
    Mascelli MA; Worley S; Veriabo NJ; Lance ET; Mack S; Schaible T; Weisman HF; Jordan RE
    Circulation; 1997 Dec; 96(11):3860-6. PubMed ID: 9403608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent.
    Cho L; Topol EJ; Balog C; Foody JM; Booth JE; Cabot C; Kleiman NS; Tcheng JE; Califf R; Lincoff AM
    J Am Coll Cardiol; 2000 Aug; 36(2):381-6. PubMed ID: 10933346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
    Boersma E; Akkerhuis KM; Théroux P; Califf RM; Topol EJ; Simoons ML
    Circulation; 1999 Nov; 100(20):2045-8. PubMed ID: 10562258
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.